Bob Burrows | VP, IR |
Dan Abdun Nabi | CEO |
Bob Kramer | President and COO |
Richard Lindahl | EVP, CFO and Treasurer |
Adam R. Havey | EVP, Business Operations |
Christopher Staral | Goldman Sachs |
Keay Nakae | Chardan Capital Markets |
Jessica Fye | JPMorgan |
David Maris | Wells Fargo |
François Brisebois | Laidlaw |
Lisa Springer | Singular Research |
Good day, ladies and gentlemen, and welcome to the Emergent BioSolutions 1Q 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to the company, Emergent BioSolutions.